Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2012

View Archived Issues

Verva reports on proof-of-concept trial of repurposed drug

Spanish scientists discover new integrin antagonists

Janssen Pharmaceuticals presents novel mGlu2 receptor modulators

Actelion Pharmaceuticals synthesizes novel orexin receptor antagonists

Novel mineralocorticoid receptor antagonists presented

Janssen and Medivir develop novel agents for hepatitis

Gene therapy for choroideremia enters clinic

AstraZeneca TLR7 agonist assessed in four clinical trials

AX-01128 protects kidney transplant function in vivo

Researchers at the CNRS disclose novel inhibitors of tubulin polymerization

Amorfix licenses diagnostic test for Alzheimer's disease to JSW Life Sciences

FDA grants fast track designation to NKTR-181

Takeda transfers TAK-070 to university

Arrowhead Research prepares to file IND

FDA approves Horizant for new indication

Alnylam completes enrollment in phase I ALN-TTR02 study and begins phase II trial

Astellas makes first Dificlir sales in Europe, triggering milestone payment to Optimer

Trovagene and Strand Life Sciences enter collaboration in India and South Asia

U.K.'s NICE issues preliminary opinion on cost-effectiveness of Bronchitol for cystic fibrosis

Ongoing EULAR conference features long-term adalimumab efficacy data in spondylarthritis

FDA extends regulatory review period for ultralong-acting insulins

Sorrento Therapeutics receives new NIH grant

Mesoblast outlines plans to develop stem cell therapies for neurodegenerative diseases

AR-42 gets E.U. orphan drug status for two additional indications

Researchers describe novel monovalent CD28-targeted Fab' antibody fragment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...